TELOSAF TRIO 12.5 (Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg))

Telosaf Trio 12.5mg Tablet is a formulation that combines multiple medications intended for the management of hypertension, or elevated blood pressure, particularly when a single medication fails to achieve adequate control. This combination therapy is designed to effectively lower blood pressure, thereby diminishing the likelihood of serious cardiovascular events such as heart attack or stroke. It is recommended to take the tablet with meals to enhance absorption and mitigate gastrointestinal discomfort. The prescribed dosage will be tailored to individual health conditions and response to treatment, and consistency in administration at the same time each day is encouraged for optimal results. It is crucial to continue the medication as directed by a healthcare provider, even in the absence of noticeable symptoms, as untreated high blood pressure can lead to significant health risks. Notably, this tablet includes a diuretic component, which may increase urination; thus, it is advisable to refrain from taking it close to bedtime to avoid nocturia. Monitoring hydration is important to alleviate potential side effects such as muscle weakness, dry mouth, and excessive thirst. Patients are urged to engage in regular follow-up appointments to monitor blood pressure, kidney function, electrolyte levels, and blood glucose, ensuring the medication’s efficacy and safety.